These corrections reflect the current published evidence. Where research is genuinely uncertain, we say so — we don't replace one myth with overclaiming in the other direction.
“Peptides are just another form of steroids”
Peptides and anabolic steroids are chemically unrelated. Steroids are small lipid-soluble molecules derived from cholesterol that bind to androgen receptors and alter gene transcription. Peptides are chains of amino acids that act on specific receptors — most never enter cells at all. BPC-157 does not suppress the HPTA. CJC-1295 does not aromatise into oestrogen. The mechanisms, side effect profiles, and regulatory categories are entirely different.
“GH peptides are the same as injecting HGH”
GH secretagogues (CJC-1295, ipamorelin, GHRP-2, sermorelin) work by stimulating the pituitary to release your own endogenous growth hormone in natural pulses. This is physiologically different from injecting exogenous recombinant HGH, which overrides pulsatile release and suppresses GHRH secretion. The dose ceilings are also lower — GH secretagogues can only release as much GH as your pituitary can produce.
“If it's WADA banned, it must be dangerous”
WADA bans substances that provide performance advantage to athletes — safety is a secondary consideration. Caffeine, altitude tents, and blood transfusions have all had WADA status changes unrelated to safety. BPC-157 is not WADA banned. Many banned peptides are banned because they are performance-enhancing, not because of safety concerns at research doses.
“Peptides are natural, so they're safe”
Many peptides are endogenous or structurally similar to endogenous sequences — but that doesn't mean any dose, at any time, in any context is safe. Insulin is a natural peptide. Excessive exogenous insulin kills. 'Natural' is a marketing claim, not a safety assessment. Evaluate each compound on its own evidence base.
“Peptides are addictive”
There is no evidence of physical dependence or addiction to the peptides discussed here. PT-141 (bremelanotide) acts on melanocortin receptors and affects desire — it can create a strong psychological preference for the experience, but this is categorically different from chemical dependence. GH secretagogues can cause pituitary downregulation with prolonged unsuppressed use — which is why cycling off matters — but this is not addiction.
“Oral peptide products work the same as injectable”
Most research peptides are rapidly degraded by stomach acid and digestive enzymes (proteases) before they can reach systemic circulation. A 5 mg oral 'BPC-157' capsule delivers a fraction of what a 500 mcg subcutaneous injection does, if anything meaningful at all. There are exceptions — some very short peptides (di- and tripeptides) can survive digestion. Always check the specific research for any oral route you're considering.
“Peptides are illegal”
Legality depends on jurisdiction and context. In most countries including Australia, research peptides occupy a regulatory grey area — they are not approved for human use, but possession for personal research is generally not prosecuted. They cannot be sold as treatments. This is distinct from being 'illegal to possess.' Check your local regulations and seek legal advice for clarity in your jurisdiction.
“Peptides have no side effects”
All biologically active compounds have dose-dependent effects, some of which are unwanted. Common ones include: water retention (especially GH secretagogues), increased hunger (GHRP-2/6), flushing and nausea (PT-141), transient fatigue, and injection-site reactions. Serious adverse events are rare at typical research doses but do occur — particularly with poor injection technique, contaminated products, or contraindicated health conditions.
“You'll see results within days”
Most peptides require weeks to months of consistent use to show measurable outcomes. Healing peptides like BPC-157 may show early pain reduction in 1–2 weeks, but structural repair takes longer. GH secretagogues typically require 6–12 weeks for meaningful body composition changes. Expecting dramatic results in the first week sets up for abandoning protocols that would have worked given time.
“Higher doses produce better results”
Peptides generally exhibit bell-curve dose-response relationships — there is an effective range, and going above it produces diminishing returns or adverse effects. GH secretagogues at very high doses can desensitise the pituitary. BPC-157 studies consistently show efficacy at 250–500 mcg/day with no clear benefit above that range. Always work within documented dose ranges.